Publicacións en colaboración con investigadores/as de Hospital San Pedro de Alcántara (49)

2024

  1. Identification of copy-number variants in patients with overgrowth disorders

    Clinical Genetics, Vol. 106, Núm. 5, pp. 614-624

  2. Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)

    Medicina Clinica

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke

    Neurologia, Vol. 38, Núm. 3, pp. 150-158

  3. Coeliac Disease Case–Control Study: Has the Time Come to Explore beyond Patients at Risk?

    Nutrients, Vol. 15, Núm. 5

  4. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

  5. Spontaneous Variation of Ventriculo-Atrial Interval after Tachycardia Induction: Determinants and Usefulness in the Diagnosis of Supraventricular Tachycardias with Long Ventriculoatrial Interval

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  6. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

    Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5

2022

  1. Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry

    Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 4, pp. 961-967

  2. Correlation of Anti-Tissue Transglutaminase Antibodies With the Mucosal Changes and IgA Status of Children With Celiac Disease

    Journal of pediatric gastroenterology and nutrition, Vol. 75, Núm. 6, pp. 743-748

  3. Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

    ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078

  4. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  5. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

  6. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Predictors of response to exclusive enteral nutrition in newly diagnosed crohn’s disease in children: PRESENCE Study from SEGHNP

    Nutrients, Vol. 12, Núm. 4

  2. Timing of Ablation and Prognosis of Patients With Electrical Storm and Scar-Related Left Ventricular Dysfunction

    American Journal of Cardiology, Vol. 136, pp. 87-93

2019

  1. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain

    Clinical Genetics, Vol. 95, Núm. 5, pp. 615-626

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2